Source: Annual Congress 2007 - Pleural techniques and diagnosis of peripheral lung nodules



Rating:

Share or cite this content

Citations should be made in the following way:
P. Cremaschi, L. Conti, C. Catanese, G. Terzuolo, E. Gatto (Pavia, Mortara (Pv), Italy). Intrapleural interleukin 2 in the treatment of persistent pneumothorax in patients not eligible for surgery. Eur Respir J 2007; 30: Suppl. 51, 748

Member's Comments

No comment yet.

Related content which might interest you: Role of surgery in pneumothorax treatment Source: Virtual Congress 2020 – Pneumothorax: to drain or not to drain Year: 2020 Intrapleural instillation of fibrinolytics in the treatment complicated pneumonia in children. Case study Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Intrapleural fibrinolytic treatment with streptokinase for empyema during pregnancy: 2 cases Source: Annual Congress 2010 - Infections and pleural problems Year: 2010 Reasons for not receiving interventional therapy in patients with severe emphysema Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018 Thoracoscopic surgery for recurrent pneumothorax of LAM (lymphangioleiomyomatosis) patients needing lung transplantation in the future Source: Eur Respir J 2005; 26: Suppl. 49, 636s Year: 2005 The evaluation of 239 patients with bronchiectasis who had surgical therapy Source: Annual Congress 2006 - Surgery for chronic benign disease and management of complications Year: 2006 Indications and results of surgical pleurodesis for spontaneous pneumothorax Source: Annual Congress 2007 - PG16 - Management of pleural problems in your practice today Year: 2007 Treatment successes with talc pleurodesis at patients (pts.) with recurrent malignant pleural effusions (PE) Source: Eur Respir J 2002; 20: Suppl. 38, 438s Year: 2002 Analysis of early postoperative complications in patients underwent pneumonectomy for unilateral destructive pulmonary tuberculosis Source: International Congress 2019 – General thoracic surgery Year: 2019 20 years of experience with the surgical treatment of pleural empyema Source: Eur Respir J 2005; 26: Suppl. 49, 170s Year: 2005 The evaluation of 287 patients with bronchiectasis who had surgical therapy Source: Annual Congress 2010 - Infections and pleural problems Year: 2010 Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor? Source: Eur Respir J, 55 (1) 1902028; 10.1183/13993003.02028-2019 Year: 2020 Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor? Source: Eur Respir J, 55 (1) 1902323; 10.1183/13993003.02323-2019 Year: 2020 Spontaneous pneumothorax and tuberculosis: long-term follow-up Source: Eur Respir J 2011; 37: 126-131 Year: 2011 25 years of experience of the surgical treatment of pleural empyema Source: Annual Congress 2008 - Pleuropulmonary infections; thoracic trauma Year: 2008 Radiotherapy: a novel treatment for pneumothorax Source: Eur Respir J 2006; 27: 427-429 Year: 2006 Survival after endoscopic valve therapy in patients with severe emphysema Source: International Congress 2016 – Endoscopic lung volume reduction I Year: 2016 Optimizing treatment for life-threatening hemoptysis: a prospective follow-up of 101 patients over 1 year Source: Eur Respir J 2007; 30: Suppl. 51, 559s Year: 2007 Iterative therapeutic thoracocentesis as the first-line treatment of complicated parapneumonic effusion: An observational study of 79 consecutive cases Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Predictors of clinical outcome in emphysema patients with atelectasis following endoscopic valve therapy Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015